IBB vs VHT

iShares Biotechnology ETF vs Vanguard Health Care ETF

Quick take
  • • VHT has the lower expense ratio at 0.09% vs 0.44% for IBB.
  • • VHT pays a higher dividend yield (1.35%).

Side-by-side metrics

MetricIBBVHT
Expense ratio
Annual fee. Lower is better.
0.44%0.09%
Dividend yield
Trailing 12-month yield.
0.16%1.35%
AUM
Assets under management — bigger funds are typically more liquid.
$11.50B$23.73B
YTD return
30.22%22.17%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
0.600.46
P/E ratio
25.4832.41
Last price
$217.75$347.68
Inception
——
Issuer
iSharesVanguard

IBB top holdings

Top holdings · IBB
GILDGilead Sciences Inc8.94%
AMGNAmgen Inc8.31%
VRTXVertex Pharmaceuticals Inc7.87%
REGNRegeneron Pharmaceuticals Inc6.24%
MRNAModerna Inc5.49%
NTRANatera Inc3.78%
ARGXargenx SE ADR3.36%
BIIBBiogen Inc2.52%
RVMDRevolution Medicines Inc Ordinary Shares2.50%
ILMNIllumina Inc2.41%
Sector breakdown · IBB
Healthcare100.0%

VHT top holdings

Top holdings · VHT
LLYEli Lilly and Co12.93%
JNJJohnson & Johnson8.78%
ABBVAbbVie Inc6.45%
MRKMerck & Co Inc5.01%
UNHUnitedHealth Group Inc4.65%
TMOThermo Fisher Scientific Inc3.50%
AMGNAmgen Inc3.18%
GILDGilead Sciences Inc2.58%
ABTAbbott Laboratories2.40%
PFEPfizer Inc2.27%
Sector breakdown · VHT
Technology0.0%
Financial Services0.0%
Industrials0.0%
Healthcare100.0%

About IBB

IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About VHT

VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $23.7B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.35%. Its largest holding is Eli Lilly and Co (LLY), which represents 12.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.